Abstract
Based on the previous experiments with the N17 mutant of CDC42, it has been speculated, but not proved as yet, that CDC42 is required for Ras-induced malignant transformation of fibroblasts. However, since this inhibitor could sequester many GDP-dissociation stimulators (GDSs), such as DBL, OST and Tiam-1 which activate not only CDC42, but also Rho or Rac, in fact it is not a specific inhibitor that inactivates only CDC42. Thus, we have taken the minimum CDC42-binding domain (residues 504 – 545, called ACK42) of the Tyr-kinase ACK-1 that binds only CDC42 in the GTP-bound form, and thereby blocking the interactions of CDC42-GTP with its downstream effectors such as ACKs, PAKs and N-WASP. First of all, using the ACK42-GST fusion protein as a specific ligand for the GTP-CDC42 complex, we have revealed that CDC42 is activated by oncogenic Ras mutants such as v-Ha-Ras in NIH3T3 fibroblasts, and similarly in PC12 cells by both NGF (Nerve Growth Factor) and EGF (Epidermal Growth Factor) which activate the endogenous normal Ras, providing the first direct evidence that CDC42 acts downstream of Ras and NGF/EGF. Furthermore, over-expression of ACK42 completely reversed Ras-induced malignant phenotypes such as focus formation and anchorage/serum-independent growth of the fibroblasts, and a cell-permeable derivative of ACK42 called WR-ACK42 strongly inhibited the growth of Ras transformants, with little effect on the parental normal cell growth, and also abolished Ras-induced filopodium/microspike formation of the fibroblasts which is CDC42-dependent. These observations unambiguously proved for the first time that the RAS-induced activation of CDC42 is indeed essential for Ras to transform the fibroblasts, and furthermore suggest that ACK42 or its peptidomimetics are potentially useful for genotherapy or chemotherapy of Ras-associated cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- ACK42:
-
CDC42-binding fragment of ACK-1
- AGE:
-
agarose gel electrophoresis
- BB2R:
-
bradykinin B2 receptor
- FCS:
-
fetal calf serum
- GAP:
-
GTPase activating protein
- GDSs:
-
GDP-dissociation stimulators
- GST:
-
glutathione S-transferase
- IPTG:
-
isopropyl-beta-galactopyranoside
- NGF:
-
nerve growth factor
- NOG:
-
neurite outgrowth
- PAGE:
-
polyacrylamide gel electrophoresis
- PCR:
-
polymerase chain reaction
- SDS:
-
sodium dodecylsulphate
- WR-ACK42:
-
cell-permeable ACK42 derivative
References
Aramori I, Zenkoh J, Morikawa N, O'Donnell N, Asano M, Nakamura K, Iwami M, Kojo H and Notsu Y. . 1997 Mol. Pharmacol. 51: 171–176.
Crespo P, Schuebel KE, Ostrom AA, Gutkind JS and Bustelo XR. . 1997 Nature 385: 169–172.
De Rooji J and Bos JL. . 1997 Oncogene 14: 623–625.
Derossi D, Chassaing G and Prochiantz A. . 1998 Trends Cell Biol. 8: 84–87.
Downward J, de Gunzburg J, Riehl R and Weinberg R. . 1988 Proc. Natl. Acad. Sci. USA 85: 5774–5778.
Feig L. . 1999 Nature Cell Biol. 1: E25–E27.
Fridman M, Tikoo A, Varga M, Murphy A, Nur-E-Kamal MSA and Maruta H. . 1994 J. Biol. Chem. 269: 30105–30108.
Hall A. . 1998 Science 279: 509–514.
Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA and Broek D. . 1998 Science 279: 558–560.
Kozma R, Ahmed S, Best A and Lim L. . 1995 Mol. Cell. Biol. 15: 1942–1952.
Leblanc V, Tocque B and Delumeau I. . 1998 Mol. Cell. Biol. 18: 5567–5578.
Lebowitz PF, Davide JP and Prendergast GC. . 1995 Mol. Cell. Biol. 15: 6613–6622.
Manser E, Leung T, Salihuddin H, Tan L and Lim L. . 1993 Nature 363: 364–367.
Maruta H. . 1996 In: Regulation of the RAS Signaling Network. Maruta H and Burgess AW. (eds).. Springer-Verlag: Heidelberg. pp 139–180.
Maruta H. . 1998 In: G Proteins, Cytoskeleton Cancer. Maruta H and Kohama K. (eds).. R.G. Landes Bioscience: Austin, TX. pp 151–170.
Maruta H, Holden J, Sizeland A and D'Abaco G. . 1991 J. Biol. Chem. 266: 11661–11668.
Miki H, Sasaki T, Takai Y and Tanekawa T. . 1998 Nature 391: 93–96.
Mott HR, Owen D, Nietlispatth D, Lowe P, Manser E, Lim L and Laue ED. . 1999 Nature 399: 384–388.
Nobes CD and Hall A. . 1999 J. Cell Biol. 144: 1235–1244.
Nur-E-Kamal MSA, Sizeland A, D'Abaco G and Maruta H. . 1992 J. Biol. Chem. 267: 1415–1418.
Qiu RG, Chen J, Kirn D, McCormick F and Symons M. . 1995 Nature 374: 457–459.
Qiu RG, Abo A, McCormick F and Symons M. . 1997 Mol. Cell. Biol. 17: 3449–3458.
Rittinger K, Walker P, Ecclestone J, Nurmahomed K, Owen D, Laue E, Gamblin S and Smerdon S. . 1997 Nature 388: 693–697.
Rodriguez-Viciana P, Warne P, Khwaja A, Marte B, Das P, Waterfield M, Ridley A and Downward J. . 1997 Cell 89: 457–467.
Wang DZM, Nur-E-Kamal MSA, Tikoo A, Montague W and Maruta H. . 1997 Cancer Res. 57: 2478–2484.
Williams E, Dunican D, Green P, Howell F, Derossi D, Walsh F and Doherty P. . 1997 J. Biol. Chem. 272: 22349–22354.
Yang W and Cerione R. . 1997 J. Biol. Chem. 272: 24810–24824.
Acknowledgements
We are very grateful to Dr Ed Manser for his gift of a plasmid expressing GST-ACK42 fusion protein, Dr Shintaro Iwashita for his gift of PC12 cells, Dr William Montague for his encouragement, and Dr Herbert Geller for his expertise on the confocal microscope, and Thao Vuong Nheu for her unpublished data on ACK42 mutants. This was supported partly by grants from the UAE Terry Fox Foundation (Grant no. 96/1) and the Research Committee of the Faculty of Medicine and Health Sciences, UAE University.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nur-E-Kamal, M., Kamal, J., Qureshi, M. et al. The CDC42-specific inhibitor derived from ACK-1 blocks v-Ha-Ras-induced transformation. Oncogene 18, 7787–7793 (1999). https://doi.org/10.1038/sj.onc.1203215
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203215
Keywords
This article is cited by
-
Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization
Leukemia (2019)
-
TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells
Breast Cancer Research (2008)
-
Role of Cdc42 in neurite outgrowth of PC12 cells and cerebellar granule neurons
Molecular and Cellular Biochemistry (2006)
-
Rho GTPases in human carcinogenesis: a tale of excess
Revista de Oncología (2003)